Where are Insiders currently buying?
The following overview shows the total of open-market transactions by insiders. Other allocations, for example as salary components, have already been filtered out.
USA
| Company | Insider Count | Vol. Buys | Vol. Sells | Difference |
|---|---|---|---|---|
| Krispy Kreme | 2 | $98,962,507 | $0 | $98,962,507 |
| Absci | 8 | $80,569,600 | $0 | $80,569,600 |
| Rani Therapeutics Holdings | 1 | $71,088,067 | $0 | $71,088,067 |
| Infrastructure and Energy Alternatives | 2 | $70,070,858 | $0 | $70,070,858 |
| Acumen Pharmaceuticals | 6 | $59,356,000 | $0 | $59,356,000 |
| Cytek Biosciences | 5 | $50,343,800 | $0 | $50,343,800 |
| IMARA | 3 | $47,999,982 | $0 | $47,999,982 |
| Cricut | 1 | $47,808,706 | $0 | $47,808,706 |
| Acutus Medical | 3 | $44,999,976 | $0 | $44,999,976 |
| Enovix | 1 | $29,999,998 | $0 | $29,999,998 |
| MaxCyte | 1 | $23,400,000 | $0 | $23,400,000 |
| TCRX | 3 | $23,389,995 | $0 | $23,389,995 |
| SentinelOne | 1 | $20,264,244 | $0 | $20,264,244 |
| Omega Therapeutics | 3 | $17,037,733 | $0 | $17,037,733 |
| FAST Acquisition | 1 | $16,944,499 | $0 | $16,944,499 |
| Sight Sciences | 1 | $16,800,000 | $0 | $16,800,000 |
| Erasca | 5 | $15,441,600 | $0 | $15,441,600 |
| IMAQ | 2 | $14,288,000 | $0 | $14,288,000 |
| Templeton Global Income Fund | 1 | $12,546,524 | $0 | $12,546,524 |
| CLOE | 2 | $11,437,180 | $0 | $11,437,180 |
| Rallybio | 1 | $10,478,000 | $0 | $10,478,000 |
| Imago BioSciences | 4 | $9,413,600 | $0 | $9,413,600 |
| RYAN | 8 | $9,072,363 | $0 | $9,072,363 |
| CIM Commercial Trust | 4 | $8,933,800 | $0 | $8,933,800 |
| DIRTT Environmental Solutions | 2 | $8,509,654 | $0 | $8,509,654 |
| Icosavax | 5 | $8,420,280 | $0 | $8,420,280 |
| OBTX | 2 | $7,329,500 | $0 | $7,329,500 |
| Couchbase | 2 | $7,249,968 | $0 | $7,249,968 |
| HCW Biologics | 5 | $6,570,000 | $0 | $6,570,000 |
| JAKKS Pacific | 1 | $6,022,659 | $0 | $6,022,659 |
| Beacon Roofing Supply | 1 | $5,999,971 | $0 | $5,999,971 |
| TPG Pace Beneficial Finance | 1 | $5,748,957 | $0 | $5,748,957 |
| GGGV | 1 | $5,162,800 | $0 | $5,162,800 |
| Rapid Micro Biosystems | 2 | $5,000,000 | $0 | $5,000,000 |
| Cerevel Therapeutics Holdings | 1 | $5,000,000 | $0 | $5,000,000 |
| Ring Energy | 1 | $4,347,900 | $0 | $4,347,900 |
| The Greenbrier Companies | 2 | $4,307,659 | $84,426 | $4,223,233 |
| Rain Therapeutics | 1 | $4,113,276 | $0 | $4,113,276 |
| Golub Capital BDC | 2 | $3,145,706 | $0 | $3,145,706 |
| Molecular Templates | 1 | $2,814,158 | $0 | $2,814,158 |
| Alzamend Neuro | 1 | $2,412,222 | $4,803 | $2,407,419 |
| Wilhelmina International | 1 | $2,375,000 | $0 | $2,375,000 |
| Paycor HCM | 7 | $2,120,600 | $0 | $2,120,600 |
| MCG | 3 | $2,000,086 | $0 | $2,000,086 |
| Kaltura | 1 | $2,000,000 | $0 | $2,000,000 |
| Ivanhoe Capital Acquisition | 1 | $1,989,500 | $0 | $1,989,500 |
| Candel Therapeutics | 6 | $1,819,778 | $0 | $1,819,778 |
| Phillips Edison & Company | 3 | $1,638,000 | $0 | $1,638,000 |
| Crown Castle International | 2 | $2,144,858 | $766,080 | $1,378,778 |
| Cohen & Steers MLP Income and Energy Opportunity Fund | 1 | $1,311,410 | $0 | $1,311,410 |
All information without guarantee! No recommendation/consultation!